108 related articles for article (PubMed ID: 25708645)
1. Osteoprotegerin protects against muscular dystrophy.
Dufresne SS; Dumont NA; Bouchard P; Lavergne É; Penninger JM; Frenette J
Am J Pathol; 2015 Apr; 185(4):920-6. PubMed ID: 25708645
[TBL] [Abstract][Full Text] [Related]
2. Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy.
Dufresne SS; Boulanger-Piette A; Bossé S; Argaw A; Hamoudi D; Marcadet L; Gamu D; Fajardo VA; Yagita H; Penninger JM; Russell Tupling A; Frenette J
Acta Neuropathol Commun; 2018 Apr; 6(1):31. PubMed ID: 29699580
[TBL] [Abstract][Full Text] [Related]
3. Osteoprotegerin and β
Dufresne SS; Boulanger-Piette A; Frenette J
Am J Pathol; 2017 Mar; 187(3):498-504. PubMed ID: 28041995
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.
Messina S; Bitto A; Aguennouz M; Minutoli L; Monici MC; Altavilla D; Squadrito F; Vita G
Exp Neurol; 2006 Mar; 198(1):234-41. PubMed ID: 16410003
[TBL] [Abstract][Full Text] [Related]
5. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
Schertzer JD; Ryall JG; Lynch GS
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
[TBL] [Abstract][Full Text] [Related]
6. Effect of taurine on excitation-contraction coupling of extensor digitorum longus muscle of dystrophic mdx mouse.
De Luca A; Pierno S; Camerino C; Huxtable RJ; Camerino DC
Adv Exp Med Biol; 1998; 442():115-9. PubMed ID: 9635022
[No Abstract] [Full Text] [Related]
7. Sarcoplasmic reticulum function in slow- and fast-twitch skeletal muscles from mdx mice.
Divet A; Huchet-Cadiou C
Pflugers Arch; 2002 Aug; 444(5):634-43. PubMed ID: 12194017
[TBL] [Abstract][Full Text] [Related]
8. EDL and soleus muscles of the C57BL6J/dy2j laminin-alpha 2-deficient dystrophic mouse are not vulnerable to eccentric contractions.
Head SI; Bakker AJ; Liangas G
Exp Physiol; 2004 Sep; 89(5):531-9. PubMed ID: 15184359
[TBL] [Abstract][Full Text] [Related]
9. Power output of fast and slow skeletal muscles of mdx (dystrophic) and control mice after clenbuterol treatment.
Lynch GS; Hinkle RT; Faulkner JA
Exp Physiol; 2000 May; 85(3):295-9. PubMed ID: 10825417
[TBL] [Abstract][Full Text] [Related]
10. First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant.
Burdi R; Didonna MP; Pignol B; Nico B; Mangieri D; Rolland JF; Camerino C; Zallone A; Ferro P; Andreetta F; Confalonieri P; De Luca A
Neuromuscul Disord; 2006 Apr; 16(4):237-48. PubMed ID: 16542837
[TBL] [Abstract][Full Text] [Related]
11. Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers.
Vandebrouck C; Martin D; Colson-Van Schoor M; Debaix H; Gailly P
J Cell Biol; 2002 Sep; 158(6):1089-96. PubMed ID: 12235126
[TBL] [Abstract][Full Text] [Related]
12. Passive mechanical properties of maturing extensor digitorum longus are not affected by lack of dystrophin.
Wolff AV; Niday AK; Voelker KA; Call JA; Evans NP; Granata KP; Grange RW
Muscle Nerve; 2006 Sep; 34(3):304-12. PubMed ID: 16770793
[TBL] [Abstract][Full Text] [Related]
13. The effects of hyperthyroidism on muscular dystrophy in the mdx mouse: greater dystrophy in cardiac and soleus muscle.
Anderson JE; Liu L; Kardami E
Muscle Nerve; 1994 Jan; 17(1):64-73. PubMed ID: 8264704
[TBL] [Abstract][Full Text] [Related]
14. GLPG0492, a novel selective androgen receptor modulator, improves muscle performance in the exercised-mdx mouse model of muscular dystrophy.
Cozzoli A; Capogrosso RF; Sblendorio VT; Dinardo MM; Jagerschmidt C; Namour F; Camerino GM; De Luca A
Pharmacol Res; 2013 Jun; 72():9-24. PubMed ID: 23523664
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the therapeutic potential of carbonic anhydrase inhibitors in two animal models of dystrophin deficient muscular dystrophy.
Giacomotto J; Pertl C; Borrel C; Walter MC; Bulst S; Johnsen B; Baillie DL; Lochmüller H; Thirion C; Ségalat L
Hum Mol Genet; 2009 Nov; 18(21):4089-101. PubMed ID: 19648295
[TBL] [Abstract][Full Text] [Related]
16. Intracellular activity of sodium in normal and dystrophic skeletal muscle from C57BL/6J mice.
Ward KM; Wareham AC
Exp Neurol; 1984 Mar; 83(3):629-33. PubMed ID: 6698162
[TBL] [Abstract][Full Text] [Related]
17. Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice.
Schertzer JD; Gehrig SM; Ryall JG; Lynch GS
Am J Pathol; 2007 Oct; 171(4):1180-8. PubMed ID: 17823291
[TBL] [Abstract][Full Text] [Related]
18. Age-related differences in regeneration of dystrophic (mdx) and normal muscle in the mouse.
Pastoret C; Sebille A
Muscle Nerve; 1995 Oct; 18(10):1147-54. PubMed ID: 7659109
[TBL] [Abstract][Full Text] [Related]
19. The promotion of osteoclastogenesis by sulfated hyaluronan through interference with osteoprotegerin and receptor activator of NF-κB ligand/osteoprotegerin complex formation.
Salbach-Hirsch J; Kraemer J; Rauner M; Samsonov SA; Pisabarro MT; Moeller S; Schnabelrauch M; Scharnweber D; Hofbauer LC; Hintze V
Biomaterials; 2013 Oct; 34(31):7653-61. PubMed ID: 23871544
[TBL] [Abstract][Full Text] [Related]
20. Physiological role of receptor activator nuclear factor-kB (RANK) in denervation-induced muscle atrophy and dysfunction.
Dufresne SS; Boulanger-Piette A; Bossé S; Frenette J
Receptors Clin Investig; 2016 May; 3(2):e13231-e13236. PubMed ID: 27547781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
